Advisory Committee Votes to Recommend EUA for Moderna Vaccine
THURSDAY, Dec. 17, 2020 -- The Moderna COVID-19 vaccine received recommendation from a U.S. Food and Drug Administration advisory committee on Thursday, clearing the way for it to become the second COVID-19 vaccine to be granted emergency use authorization.
After a day-long series of presentations on the vaccine data, the Vaccines and Related Biological Products Advisory Committee voted on the question, "Based on the totality of scientific evidence available, do the benefits of the Moderna COVID-19 Vaccine outweigh its risks for use in individuals 18 years of age and older?" The vote to recommend was nearly unanimous with 20 yes votes and one abstention.
The FDA is likely to authorize the vaccine Friday, the Washington Post reports. Gen. Gustave F. Perna, who is overseeing the federal vaccine distribution effort, said the government is preparing to ship nearly 6 million doses of the Moderna vaccine to 3,285 locations within the first week after approval.
On Tuesday, the FDA released briefing documents with a data review showing that the Moderna vaccine, which is administered in two doses one month apart, was found to be 94 percent effective in a clinical trial and had no serious safety concerns.
The Moderna vaccine was developed in partnership with the National Institute of Allergy and Infectious Diseases, with a government investment of $4.1 billion for research, development, and advanced purchase of 200 million doses.
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Further Support and Information on COVID-19
Read this next
TUESDAY, Jan. 26, 2021 -- The first known U.S. case of a more infectious Brazilian variant of the coronavirus has been confirmed in a person in Minnesota who recently traveled to...
TUESDAY, Jan. 26, 2021 -- Nearly three-quarters of individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remain asymptomatic, according to a...
TUESDAY, Jan. 26, 2021 -- From April to August 2020, there was an increase in unintentional ocular exposure to alcohol-based hand sanitizers (ABHS) among children compared with...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.